Robert J Dawe1,2, Lei Yu1,3, Konstantinos Arfanakis1,2,4, Julie A Schneider1,3,5, David A Bennett1,3, Patricia A Boyle1,6. 1. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois. 2. Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois. 3. Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois. 4. Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois. 5. Department of Pathology, Rush University Medical Center, Chicago, Illinois. 6. Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois.
Abstract
INTRODUCTION: Reduced hippocampal volume is associated with late-life cognitive decline, but prior studies have not determined whether this association persists after accounting for Alzheimer's disease (AD) and other neuropathologies. METHODS: Participants were 531 deceased older adults from community-based cohort studies of aging who had undergone annual cognitive evaluations. At death, brain tissue underwent neuropathologic examination and magnetic resonance imaging (MRI). Linear mixed models examined whether hippocampal volume measured via MRI accounted for variation in decline rate of global cognition and five cognitive domains, above and beyond neuropathologic indices. RESULTS: Demographics and indices of AD, cerebrovascular disease, Lewy body disease, hippocampal sclerosis, TDP-43, and atherosclerosis accounted for 42.6% of the variation in global cognitive decline. Hippocampal volume accounted for an additional 5.4% of this variation and made similar contributions in four of the five cognitive domains. DISCUSSION: Hippocampal volume is associated with late-life cognitive decline, above and beyond contributions from common neuropathologic indices.
INTRODUCTION: Reduced hippocampal volume is associated with late-life cognitive decline, but prior studies have not determined whether this association persists after accounting for Alzheimer's disease (AD) and other neuropathologies. METHODS:Participants were 531 deceased older adults from community-based cohort studies of aging who had undergone annual cognitive evaluations. At death, brain tissue underwent neuropathologic examination and magnetic resonance imaging (MRI). Linear mixed models examined whether hippocampal volume measured via MRI accounted for variation in decline rate of global cognition and five cognitive domains, above and beyond neuropathologic indices. RESULTS: Demographics and indices of AD, cerebrovascular disease, Lewy body disease, hippocampal sclerosis, TDP-43, and atherosclerosis accounted for 42.6% of the variation in global cognitive decline. Hippocampal volume accounted for an additional 5.4% of this variation and made similar contributions in four of the five cognitive domains. DISCUSSION: Hippocampal volume is associated with late-life cognitive decline, above and beyond contributions from common neuropathologic indices.
Authors: Ainie Soetanto; Robert S Wilson; Konrad Talbot; Ashley Un; Julie A Schneider; Mark Sobiesk; Jeremiah Kelly; Sue Leurgans; David A Bennett; Steven E Arnold Journal: Arch Gen Psychiatry Date: 2010-05
Authors: Robert S Wilson; Patricia A Boyle; Lei Yu; Lisa L Barnes; Joel Sytsma; Aron S Buchman; David A Bennett; Julie A Schneider Journal: Neurology Date: 2015-08-26 Impact factor: 9.910
Authors: J L Whitwell; B F Boeve; S D Weigand; M L Senjem; J L Gunter; M C Baker; M DeJesus-Hernandez; D S Knopman; Z K Wszolek; R C Petersen; R Rademakers; C R Jack; K A Josephs Journal: Eur J Neurol Date: 2015-02-12 Impact factor: 6.089
Authors: C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E G Tangalos; E Kokmen Journal: Neurology Date: 2000-08-22 Impact factor: 9.910
Authors: Patricia A Boyle; Robert S Wilson; Lei Yu; Alasdair M Barr; William G Honer; Julie A Schneider; David A Bennett Journal: Ann Neurol Date: 2013-07-10 Impact factor: 10.422
Authors: Claire E Sexton; Clare E Mackay; Jane A Lonie; Mark E Bastin; Emma Terrière; Ronan E O'Carroll; Klaus P Ebmeier Journal: Psychiatry Res Date: 2010-09-15 Impact factor: 3.222
Authors: Zoe Arvanitakis; Sue E Leurgans; Zhenxin Wang; Robert S Wilson; David A Bennett; Julie A Schneider Journal: Ann Neurol Date: 2010-11-08 Impact factor: 10.422
Authors: Robert J Dawe; Lei Yu; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Konstantinos Arfanakis; David A Bennett; Patricia A Boyle Journal: Neurobiol Aging Date: 2016-06-06 Impact factor: 4.673
Authors: Alessandro Orlando; A Richey Sharrett; Andrea L C Schneider; Rebecca F Gottesman; David S Knopman; Andreea Rawlings; Thomas H Mosley; Clifford R Jack; Dean Wong; James R Pike; Josef Coresh Journal: Neuroepidemiology Date: 2022-05-02 Impact factor: 5.393
Authors: Shefali Chaudhary; Simon Zhornitsky; Herta H Chao; Christopher H van Dyck; Chiang-Shan R Li Journal: Am J Alzheimers Dis Other Demen Date: 2022 Jan-Dec Impact factor: 2.632
Authors: Ilinca Popp; Alexander Rau; Elias Kellner; Marco Reisert; Jamina Tara Fennell; Thomas Rothe; Carsten Nieder; Horst Urbach; Karl Egger; Anca Ligia Grosu; Christoph P Kaller Journal: Front Oncol Date: 2021-08-19 Impact factor: 6.244
Authors: Davis C Woodworth; Nasim Sheikh-Bahaei; Kiana A Scambray; Michael J Phelan; Mari Perez-Rosendahl; María M Corrada; Claudia H Kawas; Seyed Ahmad Sajjadi Journal: Brain Commun Date: 2022-03-07
Authors: Duygu Tosun; Zeynep Demir; Dallas P Veitch; Daniel Weintraub; Paul Aisen; Clifford R Jack; William J Jagust; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; John Q Trojanowski; Michael W Weiner Journal: Alzheimers Dement Date: 2021-10-14 Impact factor: 16.655